Delivery Order SPE2DB24D2109-SPE2DB25FHXST
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $3,842.76. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, valued at $1,280.92. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency (DLA) awarded a $3,252.60 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 100 ml bottles of the prescription drug Epidiolex. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which allows DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide Epidiolex 100 mg/ml solution in a 100 ml pack. The contract has a completion date of February 16, 2024, and a potential value of $1,626.30. Amerisourcebergen Drug Corporation is the prime contractor on this delivery order, which is part of a larger indefinite...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,280.92 contract is for the supply of EPIDIOLEX 100 MG/ML SOLN PACK 60ML, a prescription medication. The contract has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This is a $8,412.50 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of EPIDIOLEX 100 MG/ML SOLN PACK 100ML. The award has a completion date of June 4, 2025 and is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EPIDIOLEX 100 MG/ML SOLN PACK 100ML. The fixed-price contract has a ceiling value of $8,412.50 and a period of performance through July 3, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop Support Medical, which provides a comprehensive global...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXSTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs, with a ceiling value of $1,682.50 and an ultimate completion date of September 8, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations as a major pharmaceutical distributor to federal healthcare systems. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs. Epidiolex, an FDA-approved cannabidiol-based treatment for seizure disorders, represents a specialized pharmaceutical product within the company's extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/15/25 |